Role of Menopause in Thermoregulation
Launched by PENN STATE UNIVERSITY · Jan 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how menopause affects the body’s ability to handle heat, especially in women aged 42 to 64. As people get older, their bodies don’t respond to heat as well, which can be risky, especially for women after menopause. Researchers want to understand how lower levels of estrogen, a hormone that decreases after menopause, combined with aging, influence how women manage heat stress.
To be eligible for this study, women need to be between 42 and 64 years old. However, those with certain health issues, like inflammatory bowel diseases or heart problems, or who are using hormone therapy or contraceptives, will not be able to participate. Participants in the study will help researchers learn more about the effects of menopause on heat regulation, which could lead to better health recommendations for women as they age.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women ages 42-64
- Exclusion Criteria:
- • Chron's disease, diverticulitis, or similar gastrointestinal disease
- • Abnormal resting exercise electrocardiogram (ECG)
- • Tobacco use
- • High-risk determined by the Atherosclerotic Cardiovascular Disease (CVD) Risk Factor
- • Assessment
- • Using hormone therapy
- • Using hormonal contraceptives
About Penn State University
Penn State University is a leading research institution renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical trials. As a prominent sponsor of clinical research, the university leverages its diverse expertise across various medical fields to conduct rigorous studies aimed at evaluating new treatments, interventions, and healthcare strategies. With a strong emphasis on collaboration, ethical standards, and patient safety, Penn State University is dedicated to translating research findings into real-world applications that enhance the well-being of communities and contribute to the broader scientific landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
University Park, Pennsylvania, United States
Patients applied
Trial Officials
W. Larry Kenney, Ph.D.
Principal Investigator
The Pennsylvania State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported